ClinicalTrials.gg
Sign In

Neoplasms, Plasma Cell clinical trials

The registry lists 710 studies for Neoplasms, Plasma Cell across more than 10 countries. 79 are recruiting or about to start. 90 of them are mainly about Neoplasms, Plasma Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 5 narrower conditions too, such as Multiple Myeloma: 4,467 studies, 926 open.

ClinicalTrials.gov finds 4,525 studies for Neoplasms, Plasma Cell. How that becomes 709 here

This page counts the studies the registry files under Neoplasms, Plasma Cell, and those it files under no condition that list Neoplasms, Plasma Cellthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 4,525Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −3,657Filed under a narrower condition, counted on its own pageMultiple Myeloma 3,148 · Waldenstrom Macroglobulinemia 358 · Immunoglobulin Light-chain Amyloidosis 133 · Leukemia, Plasma Cell 11 · Plasmacytoma 7
  3. −159Match it another way159 by a synonym or other text the search reads.
  4. 709The count on this page3 of them list Neoplasms, Plasma Cell in their own words; the registry filed them under no condition.

Get an email when these change. Save the Neoplasms, Plasma Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
423
Terminated
103
Recruiting
58
Status unknown
56
Active, not recruiting
26
Withdrawn
22

Phase

Phase 2
342
Phase 1
215
Phase 3
72
Early Phase 1
15
Phase 4
6

Where

United States
502
France
47
United Kingdom
39
China
32
Canada
28
Australia
22

Who runs them

M.D. Anderson Cancer Center (35) · Mayo Clinic (26) · Memorial Sloan Kettering Cancer Center (22) · Fred Hutchinson Cancer Center (18) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (17) · Case Comprehensive Cancer Center (14) · H. Lee Moffitt Cancer Center and Research Institute (14) · Masonic Cancer Center, University of Minnesota (13)

What is being tested here

Drugs under test in Neoplasms, Plasma Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone91168
Lenalidomide7742
Immunoglobulins, Intravenous445
Immunoglobulin G445
Daratumumab3113
Elranatamab315
Belantamab mafodotin304
Bortezomib2550
Cyclophosphamide2347
Fludarabine2141

Drug classes tested here Corticosteroids 9 open · Proteasome inhibitors 4 open · Alkylating agents 2 open · Antimetabolites 2 open · Beta-lactamase inhibitors 2 open

Coming up

10phase 3 studies under way
31studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 58 Neoplasms, Plasma Cell studies recruiting now, 34 (59%) set no upper age limit and 12 (21%) stop at 75 or younger. 4 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (12%) take healthy volunteers.

Recruiting studies that take each age, of 58
AgeWomenMen
104 (7%)4 (7%)
1853 (91%)53 (91%)
3055 (95%)55 (95%)
4056 (97%)56 (97%)
5055 (95%)55 (95%)
6556 (97%)56 (97%)
7555 (95%)55 (95%)
8540 (69%)40 (69%)

Across all 710 studies, recruiting or not: 27% stop at 75 or younger and 12% at 65; 20% take children; 0% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neoplasms, Plasma Cell studies take

Of 67 phase 2 interventional studies under Neoplasms, Plasma Cell, half reached primary completion within 58 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 160 mo27–86 · 51 studies—61 mo24–96 · 35 studies
Phase 258 mo38–94 · 67 studies—59 mo39–89 · 61 studies
Phase 367 mo36–97 · 19 studies——
Interventional, no phase37 mo22–144 · 25 studies——
Observational71 mo34–148 · 31 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted1

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 710. Browse all 710 → or search them.